biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	4A79E1D5-C36E-4A07-969F-59EFD78FC2D9
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A3A1-11A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A3A1-11A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A3A1-11A
biospecimen__bio__biospecimen_barcode_bottom	0122967752
biospecimen__bio__day_of_creation	30
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	01
biospecimen__bio__plate_column	9
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A3A1
biospecimen__shared__patient_id	A3A1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	708BC79F-62DE-4EBF-922F-EEBA3B47CE91
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	6
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	11.2
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.1
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	65
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A3A1-F42704
clinical__clin_shared__bcr_followup_uuid	329F38BF-FFA2-479C-A082-40C29BCFA689
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	1
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	178
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2001
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3b
clinical__shared_stage__system_version	5th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	f042224a-ac27-4c6f-9d2c-a5c4eb44a1c0
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A3A1-11A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	98f57662-699f-4d78-a571-8c1f9e56a043
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	b113dbfb-cb9f-408b-afb1-eb02a76ca014
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	877b9f6b-9b34-40ed-933f-8fef204edf21
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:54:50.037061-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	f3156e8e-02cf-517e-b665-40bcf923c69c
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	not reported
gdc__demographic__year_of_birth	1936
gdc__demographic__year_of_death	2001
gdc__diagnoses__age_at_diagnosis	24046
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24046.0
gdc__diagnoses__days_to_death	233.0
gdc__diagnoses__diagnosis_id	cf4d5896-daef-5ce7-bfa1-87a1d9bb7006
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.79035792549306
gdc__exposures__exposure_id	1b60cbdb-6440-5f79-8944-b135c62c0df0
gdc__exposures__height	185.0
gdc__exposures__weight	78.0
gdc__file_id	236d797d-a4c7-4790-a690-bdc96e301b3f
gdc__file_name	db6c70f9-0f91-4892-be97-ad787e722586.mirbase21.mirnas.quantification.txt
gdc__file_size	50355
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	fbb2913bdc680ca8403936a87ebb4c3a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	89a14fd0-85ee-4adc-8c6f-f363b96fc7ec
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	3753
gdc__samples__initial_weight	180.0
gdc__samples__oct_embedded	false
gdc__samples__sample_id	118cbeed-8dee-4253-9850-f2ba7e589a0d
gdc__samples__sample_type	Solid Tissue Normal
gdc__samples__sample_type_id	11
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	80.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	0.0
gdc__slides__percent_tumor_nuclei	0.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	40ca02b0-cbf2-40a0-9265-6765685b5818
gdc__submitter_id	mirna_swap_dr11_406_MirnaExpressiondd2a8069-2b81-42a1-964c-2bc81f73c579_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	e898b5c8-acba-5e06-bad8-6ca6db03ac44
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:56.851+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f042224a-ac27-4c6f-9d2c-a5c4eb44a1c0-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f042224a-ac27-4c6f-9d2c-a5c4eb44a1c0-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129726
manually_curated__local_md5	5d07694e93e305e9fe6dca13b59f286e
manually_curated__opengdc_download_date	2018-10-16T17:11:18.000723+02:00
manually_curated__opengdc_file_md5	7f81cc1da011228a06dcf3b9c056165c
manually_curated__opengdc_file_size	50354
manually_curated__opengdc_id	f042224a-ac27-4c6f-9d2c-a5c4eb44a1c0-meq
manually_curated__origin_file_size	129726
manually_curated__origin_last_modified_date	Tue Oct 16 17:16:00 CEST 2018
manually_curated__origin_md5	5d07694e93e305e9fe6dca13b59f286e
manually_curated__tissue_status	normal
num	1881
